Margulis, Vitaly <br/><br/>
Development of accurate models for individualized prediction of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.  [electronic resource] 

 -  European urology  May 2013 
 - 947-52 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-7560 
<br/><br/><label>Standard No.: </label>10.1016/j.eururo.2012.11.040  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biomarkers, Tumor--blood<br/>Blood Transfusion--mortality<br/>Carcinoma, Renal Cell--blood<br/>Decision Support Techniques<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Kidney Neoplasms--blood<br/>L-Lactate Dehydrogenase--blood<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Neoplasm Staging<br/>Nephrectomy--adverse effects<br/>Odds Ratio<br/>Patient Selection<br/>Precision Medicine<br/>Retrospective Studies<br/>Risk Assessment<br/>Risk Factors<br/>Serum Albumin--analysis<br/>Serum Albumin, Human<br/>Tertiary Care Centers<br/>Texas<br/>Time Factors<br/>Transfusion Reaction<br/>Treatment Outcome